Two-Year Real-World Outcomes of Faricimab in Treatment-Resistant Neovascular Age-Related Macular Degeneration.
Saved in:
| Title: | Two-Year Real-World Outcomes of Faricimab in Treatment-Resistant Neovascular Age-Related Macular Degeneration. |
|---|---|
| Authors: | Ahmed E; Department of Ophthalmology, University Hospitals of Bristol and Weston NHS Foundation Trust, Bristol, UK., Goodchild C; Department of Ophthalmology, St Vincent's University Hospital and Hermitage Medical Clinic, Dublin, Ireland., Bisoukis A; Department of Ophthalmology, University Hospitals of Bristol and Weston NHS Foundation Trust, Bristol, UK., Salvatore S; Department of Ophthalmology, University Hospitals of Bristol and Weston NHS Foundation Trust, Bristol, UK. |
| Source: | Clinical ophthalmology (Auckland, N.Z.) [Clin Ophthalmol] 2026 Jun 09; Vol. 20, pp. 596406. Date of Electronic Publication: 2026 Jun 09 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Dove Medical Press Country of Publication: New Zealand NLM ID: 101321512 Publication Model: eCollection Cited Medium: Print ISSN: 1177-5467 (Print) Linking ISSN: 11775467 NLM ISO Abbreviation: Clin Ophthalmol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
